This is the definitive crib sheet to see what is happening in global M&A. This edition comprises of over 200 pages of comment, data and statistics on the key issues in key M&A territories.
Table of Contents
1. Introduction
2. M&A faces Q&A: Non-European Investment faces political scrutiny in Germany
3. Video-sharing websites face consolidation
4. The rising importance of mid-market M&A
5. Signs that a sick market is returning to health?
6. North America
7. Latin America
8. Asia-Pacific
9. China
10. Japan
11. Australia
12. Europe
13. UK
14. Germany
15. France
16. Italy
17. Benelux
18. Iberia
19. Nordic
20. CEE/CIS
21. Russia
Despite a reasonably subdued first quarter of M&A, there have still been some deals which have defied the trend, such as the Pfizer/Wyeth deal, worth a cool $64bn. In North America in Q1 there were 539 deals worth a total of $226.3bn. The highest deal for the month of March in the region was Merck & Co’s acquisition of Schering Plough Corporation for $43.1bn, which has taken on a similar form of the reverse termination fee that was used in the Pfizer deal, demonstrating the watertight measures needed to complete a deal in the current climate.
In Europe, the first quarter of 2009 saw a total of €82.7bn from 675 deals. Of the top 15 deals, three were government bailouts. These included the much publicised bailout of Lloyds banking group and the Royal Bank of Scotland. Additionally, the Government of the Flemish region in Belgium acquired KBC Group, for €2bn. The Energy, Mining & Utilities sector featured heavily on the top deals table, with eight of the top 15 deals originating in the sector. Endesa’s takeover by Enel came in with the highest value at €11.1bn.
To view this month's report click here
We hope you find this report useful and we would particularly welcome any feedback or questions you might have.
April 29, 2010, Grand Hyatt Sao Paulo, Brazil